Literature DB >> 29126303

Inhibition of the Mitochondrial Pyruvate Carrier by Tolylfluanid.

Yana Chen1, Kyle S McCommis1, Daniel Ferguson1, Angela M Hall1, Charles A Harris1, Brian N Finck1.   

Abstract

Several recent studies have suggested that compounds known as endocrine-disrupting chemicals (EDCs) can promote obesity by serving as ligands for nuclear receptors, including the peroxisome proliferator-activated receptor γ (PPARγ) and the glucocorticoid receptor (GR). Thiazolidinedione insulin sensitizers, which act as ligands for PPARγ, also interact with and regulate the activity of the mitochondrial pyruvate carrier (MPC). We evaluated whether several EDCs might also affect MPC activity. Most of the EDCs evaluated did not acutely affect pyruvate metabolism. However, the putative endocrine disruptors tributyltin (TBT) and tolylfluanid (TF) acutely and markedly suppressed pyruvate metabolism in isolated mitochondria. Using mitochondria isolated from brown adipose tissue in mice with adipocyte-specific deletion of the MPC2 protein, we determined that the effect of TF on pyruvate metabolism required MPC2, whereas TBT did not. We attempted to determine whether the obesogenic effects of TF might involve MPC2 in adipose tissue. However, we were unable to replicate the published effects of TF on weight gain and adipose tissue gene expression in wild-type or fat-specific MPC2 knockout mice. Treatment with TF modestly enhanced adipogenic gene expression in vitro but had no effect on GR activation or phosphorylation in cultured cells. These data suggest that TF may affect mitochondrial pyruvate metabolism via the MPC complex but also call into question whether this compound affects GR activity and is obesogenic in mice.
Copyright © 2018 Endocrine Society.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29126303      PMCID: PMC5774852          DOI: 10.1210/en.2017-00695

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  44 in total

1.  PPAR gamma is required for placental, cardiac, and adipose tissue development.

Authors:  Y Barak; M C Nelson; E S Ong; Y Z Jones; P Ruiz-Lozano; K R Chien; A Koder; R M Evans
Journal:  Mol Cell       Date:  1999-10       Impact factor: 17.970

2.  Corticosterone-regulated actions in the rat brain are affected by perinatal exposure to low dose of bisphenol A.

Authors:  A Poimenova; E Markaki; C Rahiotis; E Kitraki
Journal:  Neuroscience       Date:  2010-02-26       Impact factor: 3.590

3.  Characterization of novel ligands of ERα, Erβ, and PPARγ: the case of halogenated bisphenol A and their conjugated metabolites.

Authors:  Anne Riu; Albane le Maire; Marina Grimaldi; Marc Audebert; Anne Hillenweck; William Bourguet; Patrick Balaguer; Daniel Zalko
Journal:  Toxicol Sci       Date:  2011-05-27       Impact factor: 4.849

4.  A novel cell line, MDA-kb2, that stably expresses an androgen- and glucocorticoid-responsive reporter for the detection of hormone receptor agonists and antagonists.

Authors:  Vickie S Wilson; Kathy Bobseine; Christy R Lambright; L E Gray
Journal:  Toxicol Sci       Date:  2002-03       Impact factor: 4.849

5.  Targeting the mitochondrial pyruvate carrier attenuates fibrosis in a mouse model of nonalcoholic steatohepatitis.

Authors:  Kyle S McCommis; Wesley T Hodges; Elizabeth M Brunt; Ilke Nalbantoglu; William G McDonald; Christopher Holley; Hideji Fujiwara; Jean E Schaffer; Jerry R Colca; Brian N Finck
Journal:  Hepatology       Date:  2017-03-30       Impact factor: 17.425

6.  Glucocorticoid-dependency of increased adiposity in a model of hypothalamic obesity.

Authors:  Mario Perelló; Griselda Moreno; Rolf C Gaillard; Eduardo Spinedi
Journal:  Neuro Endocrinol Lett       Date:  2004 Feb-Apr       Impact factor: 0.765

7.  Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor.

Authors:  P Tontonoz; E Hu; B M Spiegelman
Journal:  Cell       Date:  1994-12-30       Impact factor: 41.582

8.  Identification of a mitochondrial target of thiazolidinedione insulin sensitizers (mTOT)--relationship to newly identified mitochondrial pyruvate carrier proteins.

Authors:  Jerry R Colca; William G McDonald; Gregory S Cavey; Serena L Cole; Danielle D Holewa; Angela S Brightwell-Conrad; Cindy L Wolfe; Jean S Wheeler; Kristin R Coulter; Peter M Kilkuskie; Elena Gracheva; Yulia Korshunova; Michelle Trusgnich; Robert Karr; Sandra E Wiley; Ajit S Divakaruni; Anne N Murphy; Patrick A Vigueira; Brian N Finck; Rolf F Kletzien
Journal:  PLoS One       Date:  2013-05-15       Impact factor: 3.240

9.  Pyruvate dehydrogenase kinase 4: regulation by thiazolidinediones and implication in glyceroneogenesis in adipose tissue.

Authors:  Thomas Cadoudal; Emilie Distel; Sylvie Durant; Françoise Fouque; Jean-Marc Blouin; Martine Collinet; Sylvie Bortoli; Claude Forest; Chantal Benelli
Journal:  Diabetes       Date:  2008-06-02       Impact factor: 9.461

10.  Prenatal bisphenol A exposure induces preneoplastic lesions in the mammary gland in Wistar rats.

Authors:  Milena Durando; Laura Kass; Julio Piva; Carlos Sonnenschein; Ana M Soto; Enrique H Luque; Mónica Muñoz-de-Toro
Journal:  Environ Health Perspect       Date:  2007-01       Impact factor: 9.031

View more
  6 in total

1.  Developmental exposure to the endocrine disruptor tolylfluanid induces sex-specific later-life metabolic dysfunction.

Authors:  Daniel Ruiz; Shane M Regnier; Andrew G Kirkley; Manami Hara; Fidel Haro; Hani Aldirawi; Michael P Dybala; Robert M Sargis
Journal:  Reprod Toxicol       Date:  2019-06-28       Impact factor: 3.143

Review 2.  The mitochondrial pyruvate carrier at the crossroads of intermediary metabolism.

Authors:  Nicole K H Yiew; Brian N Finck
Journal:  Am J Physiol Endocrinol Metab       Date:  2022-05-30       Impact factor: 5.900

Review 3.  Obesity II: Establishing causal links between chemical exposures and obesity.

Authors:  Jerrold J Heindel; Sarah Howard; Keren Agay-Shay; Juan P Arrebola; Karine Audouze; Patrick J Babin; Robert Barouki; Amita Bansal; Etienne Blanc; Matthew C Cave; Saurabh Chatterjee; Nicolas Chevalier; Mahua Choudhury; David Collier; Lisa Connolly; Xavier Coumoul; Gabriella Garruti; Michael Gilbertson; Lori A Hoepner; Alison C Holloway; George Howell; Christopher D Kassotis; Mathew K Kay; Min Ji Kim; Dominique Lagadic-Gossmann; Sophie Langouet; Antoine Legrand; Zhuorui Li; Helene Le Mentec; Lars Lind; P Monica Lind; Robert H Lustig; Corinne Martin-Chouly; Vesna Munic Kos; Normand Podechard; Troy A Roepke; Robert M Sargis; Anne Starling; Craig R Tomlinson; Charbel Touma; Jan Vondracek; Frederick Vom Saal; Bruce Blumberg
Journal:  Biochem Pharmacol       Date:  2022-04-05       Impact factor: 6.100

4.  Diet-dependence of metabolic perturbations mediated by the endocrine disruptor tolylfluanid.

Authors:  Shane M Regnier; Andrew G Kirkley; Daniel Ruiz; Wakanene Kamau; Qian Wu; Kurunthachalam Kannan; Robert M Sargis
Journal:  Endocr Connect       Date:  2017-11-29       Impact factor: 3.335

5.  The yeast mitochondrial pyruvate carrier is a hetero-dimer in its functional state.

Authors:  Sotiria Tavoulari; Chancievan Thangaratnarajah; Vasiliki Mavridou; Michael E Harbour; Jean-Claude Martinou; Edmund Rs Kunji
Journal:  EMBO J       Date:  2019-04-12       Impact factor: 11.598

6.  Characteristic Analysis of Homo- and Heterodimeric Complexes of Human Mitochondrial Pyruvate Carrier Related to Metabolic Diseases.

Authors:  Jinyi Lee; Zeyu Jin; Donghan Lee; Ji-Hye Yun; Weontae Lee
Journal:  Int J Mol Sci       Date:  2020-05-11       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.